Target intelligence / Profile preview

Rab geranylgeranyltransferase subunit alpha (RABGGTA)

Target
RABGGTA
Molecular classification
Enzyme, Protein prenyltransferase
01

Overview

Rab geranylgeranyltransferase subunit alpha (RABGGTA) is the alpha subunit of the heterodimeric Rab geranylgeranyltransferase enzyme (also called protein geranylgeranyltransferase type II). It catalyzes the transfer of geranylgeranyl moieties from geranylgeranyl diphosphate to the C-terminal cysteine residues of Rab GTPase proteins—a post-translational modification necessary for their membrane association and role in vesicular trafficking. Unlike other prenyltransferases, Rab GGTase relies on the Rab escort protein (REP) for substrate recognition and specificity. RABGGTA is essential for correct Rab protein localization and function across diverse cell types, and loss-of-function mutations can cause defects in intracellular trafficking, especially notable in blood platelets. In vitro, it can be inhibited by drugs such as nitrogen-containing bisphosphonates, though therapeutic applications are limited by essential housekeeping functions of the enzyme[1][5][6][2][9].

Other names
Geranylgeranyl transferase type-2 subunit alphaRab GG transferase alphaRab GGTase alphaPTAR3protein prenyltransferase alpha subunit repeat containing 3Rab geranyl-geranyltransferase subunit alpha
02

Mechanism of action

Inhibition of Rab GGTase activity, leading to impaired Rab protein prenylation and membrane localization[1][2]

03

Biological functions

Protein prenylationMembrane traffickingSmall GTPase signalingEndoplasmic reticulum to Golgi vesicle-mediated transport
04

Disease associations

Hematological disorders (e.g., platelet biogenesis disorders[6])Potential: Cancer[5]Potential: Neurodegenerative diseases (by analogy with Rab protein dysfunction[8])
05

Safety considerations

Potential impairment of vesicular trafficking in non-target tissuesOff-target effects on platelet formation and function due to broad involvement in membrane trafficking[6]
06

Interacting drugs

Nitrogen-containing bisphosphonates (e.g., risedronate; mainly in vitro)[1]
07

Biomarkers

Unprenylated Rab proteins (as seen in genetic or pharmacological inhibition)[6]

Beyond the preview

Go deeper on Rab geranylgeranyltransferase subunit alpha (RABGGTA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rab geranylgeranyltransferase subunit alpha (RABGGTA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call